Related Experiment Video
Updated: May 27, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
Jacqueline P Nguyen1, Shorook Na'ara1, Liam C Woerner1
1Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California.
Abstract:
Increased PI3K signaling as a result of PIK3CA mutation or amplification or decreased expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most common alterations in head and neck squamous cell carcinoma (HNSCC). PTEN negatively regulates PI3K signaling and its downstream effectors including COX2. COX2 mediates the synthesis of prostaglandin E2 (PGE2) which contributes to immunosuppression in the tumor microenvironment. PGE2 also binds to one or more EP receptors (EP1-EP4) and promotes the growth of tumor cells via activation of EP2 and EP4. However, the role of PGE2 in PTEN-deficient HNSCC is incompletely understood. In this study, we assessed PGE2 signaling in PTEN-deficient HNSCC and evaluated the effect of aspirin or TPST-1495, a dual EP2/EP4 antagonist, on the growth of PTEN knockout and PIK3CA-altered HNSCC tumors in immunocompetent mice. Our results demonstrated that aspirin selectively inhibits the growth of PTEN knockout HNSCC tumors. TPST-1495 inhibited tumor growth and substantially increased the antitumor activity of the immune checkpoint inhibitor anti-PD1. To date, there are no FDA-approved therapies for PI3K pathway-altered HNSCC. Our findings suggest that NSAIDs demonstrate antitumor activity in PTEN-deficient or PI3K-altered tumors whereas EP2/EP4 targeting may augment FDA-approved anti-PD1 therapy in HNSCC.
Insights
Aspirin inhibits head and neck squamous cell carcinoma (HNSCC) growth in PTEN-deficient tumors. Targeting EP2/EP4 receptors with TPST-1495 enhances anti-PD1 therapy effectiveness in HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- PI3K signaling is frequently altered in head and neck squamous cell carcinoma (HNSCC).
- PTEN loss or PIK3CA alterations lead to increased PI3K signaling, promoting tumor growth and immunosuppression via COX2 and prostaglandin E2 (PGE2).
- The role of PGE2 in PTEN-deficient HNSCC and its interaction with EP2/EP4 receptors require further investigation.
Purpose of the Study:
- To investigate PGE2 signaling in PTEN-deficient HNSCC.
- To evaluate the efficacy of aspirin and a dual EP2/EP4 antagonist (TPST-1495) in preclinical HNSCC models.
- To assess the potential of EP2/EP4 antagonism to enhance anti-PD1 immunotherapy.
Main Methods:
- Utilized PTEN knockout and PIK3CA-altered HNSCC cell lines and tumor models in immunocompetent mice.
- Assessed PGE2 signaling pathways and the impact of therapeutic interventions.
- Administered aspirin, TPST-1495, or anti-PD1 immunotherapy, alone or in combination.
Main Results:
- Aspirin selectively inhibited the growth of PTEN knockout HNSCC tumors.
- TPST-1495 demonstrated significant tumor growth inhibition.
- TPST-1495 substantially enhanced the antitumor activity of anti-PD1 immunotherapy.
Conclusions:
- Non-steroidal anti-inflammatory drugs (NSAIDs) exhibit antitumor activity in PTEN-deficient and PI3K-altered HNSCC.
- Targeting EP2/EP4 receptors represents a promising strategy to augment existing anti-PD1 therapies for HNSCC.
- These findings suggest novel therapeutic avenues for PI3K pathway-altered HNSCC.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

